Diagnosis of herpes simplex virus infections of the CNS

Expert Review of Molecular Diagnostics

Volumn 5, Issue 4, 2005, Pages 537-547

  Kimberlin, David W ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Cerebrospinal fluid; CSF; Encephaliris; Herpes; Herpes simplex encephalitis; Neonatal herpes; PCR; Polymerase chain reaction

Indexed keywords

MATERNAL ANTIBODY; VIRUS DNA;

ANTIBODY DETECTION; BRAIN BIOPSY; CEREBROSPINAL FLUID; CESAREAN SECTION; CLINICAL FEATURE; ELECTRON MICROSCOPY; GENE AMPLIFICATION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INCIDENCE; INFECTION RISK; NEWBORN INFECTION; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PREGNANCY; REVIEW; SENSITIVITY AND SPECIFICITY; VAGINAL DELIVERY; VIRUS CULTURE; VIRUS DETECTION;

ANIMALS; CENTRAL NERVOUS SYSTEM; HERPES SIMPLEX; HUMANS; RISK FACTORS; SIMPLEXVIRUS; TREATMENT OUTCOME;

EID: 22044451087     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.4.537     Document Type: Review

References (121)

1. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus Type 2 infection in the United States. N. Engl. J. Med. 321(1), 7-12 (1989).
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand. J. Infect. Dis. 69(Suppl.), 19-36 (1990).
3. Xu F, Schillinger JA, Sternberg MR et al. Seroprevalence and coinfection with herpes simplex virus Type 1 and Type 2 in the United States, 1988-1994. J. Infect. Dis. 185(8), 1019-1024 (2002).
4. Fleming DT, McQuillan GM, Johnson RE et al. Herpes simplex virus Type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337(16), 1105-1111 (1997).
5. Xu F, McQuillan GM, Kottiri BJ et al. Trends in herpes simplex virus type 2 infection in the United States. 42nd Annual Meeting of the Infectious Diseases Society of America. MA, USA (2004) (Abstract 739).
6. Nahmias AJ, Keyserling HL, Kerrick GM. Herpes simplex. In: Infectious Diseases of the Fetus and Newborn Infants, Second Edition. Remington JS, Klein JO (Eds), WB Saunders Company, PA, USA, 636-678 (1983).
7. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am. J. Obstet. Gynecol. 110(6), 825-837 (1971).
8. Whitley RJ. Herpes simplex virus infections. In: Infectious Diseases of the Fetus and Newborn Infants, Third Edition. Remington JS, Klein JO (Eds), WB Saunders Company, PA, USA, 282-305 (1990).
9. Kulhanjian JA, Soroush V, Au DS et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus Type 2 during pregnancy. N. Engl. J. Med. 326(14), 916-920 (1992).
10. Brown ZA, Selke S, Zeh J et al. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337(8), 509-515 (1997).
11. Whitley RJ, Corey L, Arvin A et al. Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 158(1), 109-116 (1988).
12. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 66(4), 489-494 (1980).
13. Yeager AS, Arvin AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 73(2), 188-193 (1984).
14. Bolognese RJ, Corson SL, Fuccillo DA, Traub R, Moder F, Sever JL. Herpesvirus hominis Type II infections in asymptomatic pregnant women. Obstet. Gynecol. 48(5), 507-510 (1976).
15. Brown ZA, Benedetti J, Ashley R et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 324(18), 1247-1252 (1991).
16. Tejani N, Klein SW, Kaplan M. Subclinical herpes simplex genitalis infections in the perinatal period. Am. J. Obstet. Gynecol. 135(4), 547 (1979).
17. Prober CG, Hensleigh PA, Boucher FD, Yasukawa LL, Au DS, Arvin AM. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N. Engl. J. Med. 318(14), 887-891 (1988).
18. Vontver LA, Hickok DE, Brown Z, Reid L, Corey L. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am. J. Obstet. Gynecol. 143(1), 75-84 (1982).
19. Arvin AM, Hensleigh PA, Prober CG et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med. 315(13), 796-800 (1986).
20. Brown ZA, Vontver LA, Benedetti J et al. Effects on infants of a first episode of genital herpes during pregnancy. N. Engl. J. Med. 317(20), 1246-1251 (1987).
21. Corey L, Wald A. Genital herpes. In: Sexually Transmitted Diseases, Third edition Holmes KK, Sparling PF, Mardh PA et al. (Eds), McGraw-Hill, NY, USA, 285-312 (1999).
22. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289(2), 203-209 (2003). Groundbreaking study of 60,000 women shedding herpes simplex virus (HSV) at delivery, with assessment of risk of transmission to the babies.
23. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N. Engl. J. Med. 316(5), 240-244 (1987).
24. Yeager AS, Arvin AM, Urbani LJ, Kemp JA III. Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect. Immun. 29(2), 532-538 (1980).
25. Parvey LS, Ch'ien LT. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes. Pediatrics 65(6), 1150-1153 (1980).
26. Kaye EM, Dooling EC. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 31(8), 1045-1047 (1981).
27. Sullender WM, Miller JL, Yasukawa LL et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 155(1), 28-37 (1987).
28. Kohl S, West MS, Prober CG, Sullender WM, Loo LS, Arvin AM. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J. Infect. Dis. 160(5), 770-776 (1989).
29. No authors listed. ACOG practice bulletin. Management of herpes in pregnancy. Number 8, October 1999. Clinical management guidelines for obstetrician-gynecologists. Int. J. Gynaecol. Obstet. 68(2), 165-173 (2000).
30. Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J. Perinatol. 16(5), 397-399 (1996).
31. Kimberlin DW, Lin CY, Jacobs RF et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108(2), 223-229 (2001).
32. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus Type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 181(4), 1454-1457 (2000).
33. Kimberlin DW, Rouse DJ. Genital herpes. N. Engl. J. Med. 350(19), 1970-1977 (2004). Recent thorough review of genital herpes.
34. Kimberlin DW. Neonatal HSV infections: the global picture. Herpes 11(2), 31-32 (2004).
35. Baldwin S, Whitley RJ. Intrauterine herpes simplex virus infection. Teratology 39(1), 1-10 (1989).
36. Florman AL, Gershon AA, Blackett PR, Nahmias AJ. Intrauterine infection with herpes simplex virus. Resultant congenital malformations. JAMA 225(2), 129-132 (1973).
37. Karesh JW, Kapur S, MacDonald M. Herpes simplex virus and congenital malformations. South. Med. J. 76(12), 1561-1563 (1983).
38. Monif GR, Kellner KR, Donnelly WH Jr. Congenital herpes simplex Type II infection. Am. J. Obstet. Gynecol. 152(8), 1000-1002 (1985).
39. Hutto C, Arvin A, Jacobs R et al. Intrauterine herpes simplex virus infections. J. Pediatr. 110(1), 97-101 (1987).
40. Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66(4), 495-501 (1980).
41. Whitley R, Arvin A, Prober C et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N. Engl. J. Med. 324(7), 444-449 (1991).
42. Kimberlin DW, Lin CY, Jacobs RF et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 108(2), 230-238 (2001). Most recent advances in the management of neonatal herpes.
43. Whitley R, Arvin A, Prober C et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N. Engl. J. Med. 324(7), 450-454 (1991).
44. Sullivan-Bolyai JZ, Hull HF, Wilson C, Smith AL, Corey L. Presentation of neonatal herpes simplex virus infections: implications for a change in therapeutic strategy. Pediatr. Infect. Dis. 5(3), 309-314 (1986).
45. Arvin AM, Yeager AS, Bruhn FW, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J. Pediatr. 100(5), 715-721 (1982).
46. Olson LC, Buescher EL, Artenstein MS, Parkman PD. Herpesvirus infections of the human central nervous system. N. Engl. J. Med. 277(24), 1271-1277 (1967).
47. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 357(9267), 1513-1518 (2001).
48. Skoldenberg B, Forsgren M, Alestig K et al. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet 2(8405), 707-711 (1984).
49. Puchhammer-Stockl E, Presterl E, Croy C et al. Screening for possible failure of herpes simplex virus PCR in cerebrospinal fluid for the diagnosis of herpes simplex encephalitis. J. Med. Virol. 64(4), 531-536 (2001). Thorough and noble attempt to define false-negative cerebrospinal fluid (CSF) PCRs from patients with herpes simplex encephalitis.
50. Aurelius E, Johansson B, Skoldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus Type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J. Med. Virol. 39(3), 179-186 (1993).
51. Fodor PA, Levin MJ, Weinberg A, Sandberg E, Sylman J, Tyler KL. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology 51(2), 554-559 (1998).
52. Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J. Infect. Dis. 145(6), 829-836 (1982).
53. Dennett C, Cleator GM, Klapper PE. HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom. J. Med. Virol. 53(1), 1-3 (1997).
54. Whitley R, Lakeman AD, Nahmias A, Roizman B. DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N. Engl. J. Med. 307(17), 1060-1062 (1982).
55. Whitley RJ, Soong SJ, Linneman C Jr, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. Clinical Assessment. JAMA 247(3), 317-320 (1982).
56. Whitley RJ, Soong SJ, Hirsch MS et al. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N. Engl. J. Med. 304(6), 313-318 (1981).
57. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch'ien LT, Alford CA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. N. Engl. J. Med. 297(6), 289-294 (1977).
58. Whitley RJ, Cobbs CG, Alford CA Jr et al. Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAID Collaborative Antiviral Study Group. JAMA 262(2), 234-239 (1989). Great differential for infectious and noninfectious causes of encephalitis.
59. Chataway J, Davies NW, Farmer S, Howard RS, Thompson EJ, Ward KN. Herpes simplex encephalitis: an audit of the use of laboratory diagnostic tests. QJM 97(6), 325-330 (2004). Great differential for infectious and noninfectious causes of encephalitis.
60. Hindmarsh T, Lindqvist M, Olding-Stenkvist E, Skoldenberg B, Forsgren M. Accuracy of computed tomography in the diagnosis of herpes simplex encephalitis. Acta Radiologica 369(Suppl.), 192-196 (1986).
61. Whitley RJ, Alford CA, Hirsch MS et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 314(3), 144-149 (1986).
62. Sauerbrei A, Wutzler P. Laboratory diagnosis of central nervous system infections caused by herpesviruses. J. Clin. Virol. 25(Suppl. 1), S45-S51 (2002).
63. Levine DP, Lauter CB, Lerner AM. Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis. JAMA 240(4), 356-360 (1978).
64. Vandvik B, Vartdal F, Norrby E. Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies. J. Neurol. 228(1), 25-38 (1982).
65. Vandvik B, Skoldenberg B, Forsgren M, Stiernstedt G, Jeansson S, Norrby E. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J. Neurol. 231(6), 307-312 (1985).
66. Linde A, Klapper PE, Monteyne P et al. Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Diagn. Virol. 8(2), 83-104 (1997).
67. Monteyne P, Albert F, Weissbrich B et al. The detection of intrathecal synthesis of antiherpes simplex IgG antibodies: comparison between an antigen-mediated immunoblotting technique and antibody index calculations. European Union Concerted Action on Virus Meningitis and Encephalitis. J. Med. Virol. 53(4), 324-331 (1997).
68. Whitley RJ, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin. Infect. Dis. 20(2), 414-420 (1995).
69. Rowley AH, Whitley RJ, Lakeman FD, Wolinsky SM. Rapid detection of herpessimplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet 335(8687), 440-441 (1990).
70. Troendle-Atkins J, Demmler GJ, Buffone GJ. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr. 123(3), 376-380 (1993).
71. Anderson NE, Powell KF, Croxson MC. A polymerase chain reaction assay of cerebrospinal fluid in patients with suspected herpes simplex encephalitis. J Neurol. Neurosurg. Psychiatr. 56(5), 520-525 (1993).
72. Schlesinger Y, Storch GA. Herpes simplex meningitis in infancy. Pediatr. Infect. Dis. J. 13(2), 141-144 (1994).
73. Kimura H, Futamura M, Kito H et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J. Infect. Dis. 164(2), 289-293 (1991).
74. Kimberlin DW, Lakeman FD, Arvin AM et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. J. Infect. Dis. 174(6), 1162-1167 (1996). Large series assessing PCR in neonatal HSV.
75. Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch. Dis. Child Fetal Neonatal Ed. 81(1), F24-F29 (1999). Large series assessing PCR in neonatal HSV.
76. Barbi M, Binda S, Primache V, Tettamami A, Negri C, Brambilla C. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr. Infect. Dis. J. 17(3), 251-252 (1998).
77. Diamond C, Mohan K, Hobson A, Frenkel L, Corey L. Viremia in neonatal herpes simplex virus infections. Pediatr. Infect. Dis. J. 18(6), 487-489 (1999).
78. Lakeman FD, Whidey RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J. Infect. Dis. 171(4), 857-863 (1995). Large series assessing PCR in neonatal HSV.
79. Puchhammer-Stockl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C. Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med. Virol. 32(2), 77-82 (1990).
80. Guffond T, Dewilde A, Lobert PE, Caparros-Lefebvre D, Hober D, Wattre P. Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis. Clin. Infect. Dis. 18(5), 744-749 (1994).
81. Dennett C, Klapper PE, Cleator GM, Lewis AG. CSF pretreatment and the diagnosis of herpes encephalitis using the polymerase chain reaction. J Virol. Methods 34(1), 101-104 (1991).
82. Aurelius E, Johansson B, Skoldenberg B, Staland A, Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337 (8735), 189-192 (1991). Large series assessing PCR in neonatal HSY.
83. Aslanzadeh J, Osmon DR, Wilhelm MP, Espy MJ, Smith TF. A prospective study of the polymerase chain reaction for detection of herpes simplex virus in cerebrospinal fluid submitted to the clinical virology laboratory. Mol. Cell. Probes 6(5), 367-373 (1992).
84. Ito Y, Ando Y, Kimura H, Kuzushima K, Morishima T. Polymerase chain reaction-proved herpes simplex encephalitis in children. Pediatr. Infect. Dis. J. 17(1), 29-32 (1998).
85. Mitchell PS, Espy MJ, Smith TF et al. Laboratory diagnosis of central nervous system infections with herpes simplex virus by PCR performed with cerebrospinal fluid specimens. J. Clin. Microbiol. 35(11), 2873-2877 (1997).
86. Tebas P, Nease RF, Storch GA. Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model. Am. J. Med. 105(4), 287-295 (1998).
87. Domingues RB, Tsanaclis AM, Pannuti CS, Mayo MS, Lakeman FD. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. Clin. Infect. Dis. 25(1), 86-91 (1997).
88. Klapper PE, Cleator GM, Longson M. Mild forms of herpes encephalitis. J. Neurol. Neurosurg. Psychiatr. 47(11), 1247-1250 (1984).
89. Revello MG, Baldanti F, Sarasini A, Zella D, Zavattoni M, Gerna G. Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clin. Diagn. Virol. 7(3), 183-191 (1997).
90. Wildemann B, Ehrhart K, Storch-Hagenlocher B et al. Quantitation of herpes simplex virus Type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 48(5), 1341-1346(1997).
91. DeBiasi RL, Kleinschmidt-DeMasters BK, Weinberg A, Tyler KL. Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J. Clin. Virol. 25(Suppl. 1), S5-S11 (2002). Recent report on diagnostic tools for HSV CNS disease.
92. Domingues RB, Lakeman FD, Mayo MS, Whitley RJ. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J. Clin. Microbiol 36(8), 2229-2234 (1998).
93. Domingues RB, Lakeman FD, Pannuti CS, Fink MC, Tsanaclis AM. Advantage of polymerase chain reaction in the diagnosis of herpes simplex encephalitis: presentation of 5 atypical cases. Scand. J. Infect. Dis. 29(3), 229-231 (1997).
94. Schlesinger Y, Buller RS, Brunstrom JE, Moran CJ, Storch GA. Expanded spectrum of herpes simplex encephalitis in childhood. J. Pediatr. 126(2), 234-241 (1995).
95. Farkkila M, Koskiniemi M, Vaheri A. Clinical spectrum of neurological herpes simplex infection. Acta Neurol. Scand. 87(4), 325-328 (1993).
96. Shyu WC, Lin JC, Chang BC, Harn HJ, Lee CC, Tsao WL. Recurrent ascending myelitis: an unusual presentation of herpes simplex virus Type 1 infection. Ann. Neurol. 34(4), 625-627 (1993).
97. Berger J R. Benign aseptic (Mollaret's) meningitis after genital herpes. Lancet 337(8753), 1360-1361 (1991).
98. Cohen BA, Rowley AH, Long CM. Herpes simplex Type 2 in a patient with Mollaret's meningitis: demonstration by polymerase chain reaction. Ann. Neurol. 35(1), 112-116 (1994).
99. Jensenius M, Myrvang B, Storvold G, Bucher A, Helium KB, Bruu AL. Herpes simplex virus Type 2 DNA detected in cerebrospinal fluid of 9 patients with Mollaret's meningitis. Acta Neurol. Scand. 98(3), 209-212 (1998).
100. Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes 11 (Suppl. 2), 57A-64A (2004). Recent report on diagnostic tools for HSV CNS disease.
101. Coker NJ. Bell palsy: a herpes simplex mononeuritis? Arch. Otolaryngol. Head Neck Surg. 124(7), 823-824 (1998).
102. Spruance SL. Bell palsy and herpes simplex virus. Ann. Intern. Med. 120(12), 1045-1046 (1994).
103. Graham JR. The migraine connection. Headache 21(6), 243-250 (1981).
104. Hardebo JE. An association between cluster headache and herpes simplex. N. Engl. J. Med. 314(5), 30 (1986).
105. Sureda B, Villalobos F, Gil-Neciga E, Martinez ML, Bautista J. Migraine and cerebrospinal fluid alterations: are they an expression of viral meningoencephalitis? Neurologia 2(2), 54-56 (1987).
106. Dennett C, Klapper PE, Cleator GM. Polymerase chain reaction in the investigation of 'relapse' following herpes simplex encephalitis. J. Med. Virol. 48(2), 129-132 (1996).
107. Ito Y, Kimura H, Yabuta Y et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin. Infect. Dis. 30(1), 185-187 (2000). Illustrates utility of PCR in evaluating relapse of HSV CNS disease.
108. Kimberlin D, Powell D, Gruber W et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/II trial. Pediatr. Infect. Dis. J. 15(3), 247-254 (1996).
109. Mandyla H, Anagnostakis D, Koutsovitis P, Siahanidou T, Youroukos S. Late recurrence of herpes simplex virus meningoencephalitis in two infants. Eur. J. Pediatr. 160(12), 732-735 (2001).
110. Fonseca-Aten M, Messina AF, Jafri HS, Sanchez PJ. Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics 115(3), 804-809 (2005). Illustrates the utility of PCR in evaluating relapse of HSV CNS disease.
111. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin. Infect. Dis. 34(8), 1154-1157 (2002). Thoughtful assessment of negative PCR results in patients suspected of having HSV CNS disease.
112. Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes 11(Suppl. 2), 48A-56A (2004). Recent report on diagnostic tools for HSV CNS disease.
113. Atkins JT. HSV PCR for CNS infections: pearls and pitfalls. Pediatr. Infect. Dis. J. 18(9), 823-824(1999).
114. Bouquillon C, Dewilde A, Andreoletti L et al. Simultaneous detection of 6 human herpesviruses in cerebrospinal fluid and aqueous fluid by a single PCR using stair primers. J. Med. Virol. 62(3), 349-353 (2000). Assessment of new technology to rapidly detect HSV genomes in CSF.
115. Minjolle S, Arvieux C, Gautier AL et al. Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings. J. Clin. Virol. 25(1), S59-S70 (2002). Assessment of new technology to rapidly detect HSV genomes in CSF.
116. Frias C, Matas L, Ferre X et al. Usefulness of adding multiplex nested-polymerase chain reaction assay of cerebrospinal fluid samples to routine diagnostic testing for herpesvirus encephalitis. Eur. J. Clin. Microbiol. Infect. Dis. 20(9), 670-672 (2001). Assessment of new technology to rapidly detect HSV genomes in CSF.
117. Aberle SW, Puchhammer-Stockl E. Diagnosis of herpesvirus infections of the central nervous system. J. Clin. Virol. 25(1), S79-S85 (2002). Recent report on diagnostic tools for HSV CNS disease.
118. Kawada J, Kimura H, Ito Y et al. Comparison of real-time and nested PCR assays for detection of herpes simplex virus DNA. Microbiol. Immunol. 48(5), 411-415 (2004). Assessment of new technology to rapidly detect HSV genomes in CSF.
119. Espy MJ, Uhl JR, Mitchell PS et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J. Clin. Microbiol. 38(2), 795-799 (2000). Assessment of new technology to rapidly detect HSV genomes in CSF.
120. Burrows J, Nitsche A, Bayly B, Walker E, Higgins G, Kok T. Detection and subtyping of herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol. 2(1), 12 (2002). Assessment of new technology to rapidly detect HSV genomes in CSF.
121. Hukkanen V, Rehn T, Kajander R, Sjoroos M, Waris M. Time-resolved fluorometry PCR assay for rapid detection of herpes simplex virus in cerebrospinal fluid. J. Clin. Microbiol. 38(9), 3214-3218 (2000). Assessment of new technology to rapidly detect HSV genomes in CSF.